About the journal
EJC Supplements is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 9 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 1359-6349 · 1878-1217
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 172
- Declared review time
- 9 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2015-05-04
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 9 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
172
Most recent article
7 months ago
Average review time (journal-declared via DOAJ)
9weeks
Works in OpenAlex
15236
Last recorded publication year
2021
h-index
45
i10-index
335
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2015-05-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 40%
- ORCID iDs in current deposits
- 40%
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification3
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
Show all subjects (50)
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
- Medical Imaging Techniques and Applications
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Breast Lesions and Carcinomas
- Breast Lesions and Carcinomas
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
Keywords (DOAJ)
- cancer research
- clinical oncology
- translational oncology
- cancer epidemiology
- cancer biology
- digital oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ